Phase II Trial of High-Dose Rituximab with High-dose Cytarabine Mobilization Therapy and High-Dose Thiotepa, Busulfan, and Cyclophosphamide (R-TBC) Autologous Stem Cell Transplant in Patients with CNS Involvement by Non-Hodgkin Lymphoma

BACKGROUND: High-dose thiotepa, busulfan, and cyclophosphamide (TBC) with autologous stem cell transplantation (ASCT) has been used in patients with central nervous system (CNS) involvement by non-Hodgkin lymphoma (NHL). Despite limited penetration into the CNS, rituximab (R) is active in primary CN...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer
Main Authors: Chen, Yi-Bin, Batchelor, Tracy, Li, Shuli, Hochberg, Ephraim, Brezina, Mark, Jones, Sooae, Del Rio, Candice, Curtis, Morgan, Ballen, Karen K., Barnes, Jeffrey, Chi, Andrew S., Dietrich, Jorg, Driscoll, Jessica, Gertsner, Elizabeth R., Hochberg, Fred, LaCasce, Ann S., McAfee, Steven L., Spitzer, Thomas R., Nayak, Lakshmi, Armand, Philippe
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293259/
https://ncbi.nlm.nih.gov/pubmed/25204639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29023
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker